Cigna enters definitive agreement to obtain HealthSpring for $55 per share Cigna Corporation and HealthSpring, Inc. today announced they have signed a definitive agreement under which Cigna will acquire all the outstanding shares of HealthSpring for $55 per share in cash, a 37 percent premium over the closing stock price on Friday October 21, 2011, representing a complete transaction value of approximately $3 ajanta pharma stock price .8 billion. HealthSpring’s proved leadership team, headed by its Chairman and Chief Executive Officer Herb Fritch, will lead Cigna’s growth in our rapidly growing Seniors and Medicare segments. The business combination is likely to be accretive to Cigna revenue per share in the first full year of functions.
Analyzing over 2,000 medical records in the overall Practice Research Data source , researchers identified 179 British patients who were identified as having relapsing-remitting MS originally, a form of the disease where symptoms fade and recur in unpredictable patterns. Patients who were current or previous smokers were 3.6 times as likely as individuals who had never smoked to develop secondary progressive MS, a later stage of the disease marked by constant deterioration of the central nervous program. This disease progression also occurred more quickly in individuals who were defined as current or past smokers. The study also supported earlier research showing that smoking might increase the risk of initial MS diagnosis. Current and previous smokers were 30 percent more likely to end up being identified as having MS than those who had under no circumstances smoked.